What is the correct usage and dosage of Vemurafenib/Zorbovo?

Vemurafenib/zobovo(Vemurafenib), as a BRAF kinase inhibitor, is widely used in the treatment of BRAF V600E mutation-positive unresectable or metastatic melanoma. Correct mastery of the usage and dosage of this drug is crucial to ensure efficacy, reduce adverse reactions, and improve patient compliance.

According to the recommendations of the drug instructions and international clinical guidelines, the standard dose of vemurafenib is: 960 mg orally every 12 hours, which is equivalent to taking four 240 mg tablets each time. The total daily dose is 1920mg. The first dose is usually taken in the morning, and the second dose approximately 12 hours later, in the evening. Such a dose design can ensure that the drug maintains a stable blood concentration in the body, thereby continuously inhibiting the abnormally activated BRAF pathway.

In terms of dosage, vemurafenib can be taken with food or on an empty stomach, and no special dietary restrictions are required. However, in order to reduce some gastrointestinal discomfort, it is recommended that patients take medication regularly at a fixed time. If the patient misses a dose due to special reasons, if it is more than 4 hours before the next dose, the patient can take it immediately; if it is less than 4 hours, the missed dose should be skipped to avoid repeated use of the medication in a short period of time.

In terms of treatment course, vemurafenib is a long-term targeted therapy drug and should be continued until the disease progresses or the drug is discontinued or adjusted until the patient cannot tolerate the adverse reactions. Doctors will regularly monitor the condition during medication, including tumor imaging examinations and hematology indicators, to determine efficacy and safety. At the same time, different patients may need to adjust the dosage individually due to differences in liver function, heart conditions, etc.

It is important to note that vemurafenib may interact with other drugs. For example, some drugs that affect liver enzyme metabolism may change the concentration of vemurafenib in the body. Therefore, patients must inform their doctor about all medications they are taking before use to ensure safety.

Reference: https://www.drugs.com/mtm/vemurafenib.html